首页> 外文期刊>Cukurova Medical Journal >Cerebellar Hemangioblastoma: Four Case Reports and Review of the Literature
【24h】

Cerebellar Hemangioblastoma: Four Case Reports and Review of the Literature

机译:小脑血管母细胞瘤:四例报道并文献复习

获取原文
       

摘要

Hemangioblastoma (HB) is a benign, slow-growing, highly vascular tumour of not well defined histological origin. These tumors make up about 1 to 2 percent of all intracranial neoplasms and occur primarily in the posterior fossa. Hemangioblastomas can occur sporadically but in about 20% to 30% cases, it is associated with von Hippel-Lindau (VHL) disease. Four cases of cerebellar haemangioblastoma, not associated with von Hippel-Lindau disease (sporadic haemangioblastomas), were presented and reviewed the relevant literature.Four hemangioblastomas of the central nervous system were examined with haematoxylin & eosin (H&E), reticulin stain and with a panel of antibodies including CD34, vimentin, NSE, S-100, CD99, CD56, GFAP, cytoceratin, epithelial membrane antigen (EMA), CD10. Of the 4 patients in this study 1 was male and 3 were female. Their ages ranged from 46 years to 60 years with a mean age of 54.75 years. All of them were as cystic nodules about 2-3 cm in diameter. In the histopathological examination, the tumors sections showed large and vacuolated stromal cells and numerous arborizing capillary-size blood vessels. Some tumors showed atypical nuclei. Vimentin was strongly positive both stromal cells and blood veessels in all tumors. In 4 cases of HB, some stromal cells were positive for NSE and CD99. Three tumors were positive for S-100 and CD56, two tumors were focally positive for glial fibrillary acidic protein (GFAP). CD34 immunostaining highlighted the arborizing and complex vascular network, whereas the tumor stromal cells were negative. The stromal cells were negative for epithelial markers such as cytokeratin, EMA and CD10. Ki-67 index was less than 1% of the tumor cells. Hemangioblastoma, a rare, benign tumors of uncertain histogenesis, is characterized histologically by the presence of vacuolated, lipid containing cells and a well developed, fine capillary network. The main histological differential diagnosis of HB is metastatic clear cell carcinoma. Additionally, because of the cystic mural features, pilocytic astrocytomas of the cerebellum must be separated from haemangioblastomas.
机译:血管母细胞瘤(HB)是一种良性,生长缓慢,高度血管化的肿瘤,其组织学来源不明确。这些肿瘤约占所有颅内肿瘤的1-2%,主要发生在后颅窝。血管母细胞瘤可偶尔发生,但在约20%至30%的情况下,它与von Hippel-Lindau(VHL)疾病相关。提出并回顾了4例与von Hippel-Lindau疾病无关的小脑血管母细胞瘤(散发性血管母细胞瘤),并复习了相关文献.4例中枢神经系统血管母细胞瘤用苏木精和曙红(H&E),网状蛋白染色和面板检查抗体包括CD34,波形蛋白,NSE,S-100,CD99,CD56,GFAP,细胞角蛋白,上皮膜抗原(EMA)和CD10。在这项研究的4位患者中,男性1位,女性3位。他们的年龄从46岁到60岁不等,平均年龄为54.75岁。它们都是直径约2-3厘米的囊性结节。在组织病理学检查中,肿瘤切片显示较大且空泡的基质细胞和许多乔布化的毛细管大小血管。一些肿瘤显示非典型细胞核。波形蛋白在所有肿瘤中均强烈表达为基质细胞和血管阳性。在4例HB中,一些基质细胞对NSE和CD99呈阳性。 S-100和CD56阳性的三个肿瘤,神经胶质纤维酸性蛋白(GFAP)的两个肿瘤灶性阳性。 CD34免疫染色突出了复杂的血管网络,而肿瘤基质细胞阴性。基质细胞对上皮标志物如细胞角蛋白,EMA和CD10呈阴性。 Ki-67指数小于肿瘤细胞的1%。血管母细胞瘤是一种不确定的组织发生的罕见良性肿瘤,其组织学特征是存在空泡的含脂质细胞和发达的细毛细血管网。 HB的主要组织学鉴别诊断是转移性透明细胞癌。另外,由于囊性壁的特征,小脑的细胞性星形细胞瘤必须与血管母细胞瘤分开。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号